IT1264332B1 - Composizione per il trattamento di infezioni e malattie causate dal virus dell'epatite b (hpv) - Google Patents

Composizione per il trattamento di infezioni e malattie causate dal virus dell'epatite b (hpv)

Info

Publication number
IT1264332B1
IT1264332B1 IT93TO000226A ITTO930226A IT1264332B1 IT 1264332 B1 IT1264332 B1 IT 1264332B1 IT 93TO000226 A IT93TO000226 A IT 93TO000226A IT TO930226 A ITTO930226 A IT TO930226A IT 1264332 B1 IT1264332 B1 IT 1264332B1
Authority
IT
Italy
Prior art keywords
hpv
hepatitis
infections
virus
treatment
Prior art date
Application number
IT93TO000226A
Other languages
English (en)
Inventor
Dennis W Adair
Kenneth A Smiles
Dannie King
Original Assignee
Oclassen Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oclassen Pharma Inc filed Critical Oclassen Pharma Inc
Publication of ITTO930226A0 publication Critical patent/ITTO930226A0/it
Publication of ITTO930226A1 publication Critical patent/ITTO930226A1/it
Application granted granted Critical
Publication of IT1264332B1 publication Critical patent/IT1264332B1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IT93TO000226A 1992-04-06 1993-04-05 Composizione per il trattamento di infezioni e malattie causate dal virus dell'epatite b (hpv) IT1264332B1 (it)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US86389092A 1992-04-06 1992-04-06
US95292792A 1992-09-25 1992-09-25
US07/959,004 US5432165A (en) 1992-04-06 1992-10-09 Methods for the treatment of infection caused by Hepatitis B virus (HBV)

Publications (3)

Publication Number Publication Date
ITTO930226A0 ITTO930226A0 (it) 1993-04-05
ITTO930226A1 ITTO930226A1 (it) 1994-10-05
IT1264332B1 true IT1264332B1 (it) 1996-09-23

Family

ID=27420427

Family Applications (1)

Application Number Title Priority Date Filing Date
IT93TO000226A IT1264332B1 (it) 1992-04-06 1993-04-05 Composizione per il trattamento di infezioni e malattie causate dal virus dell'epatite b (hpv)

Country Status (26)

Country Link
US (1) US5432165A (it)
EP (1) EP0565412A1 (it)
JP (1) JPH069403A (it)
CN (1) CN1081879A (it)
AP (1) AP372A (it)
AU (1) AU662804B2 (it)
BE (1) BE1009181A5 (it)
BR (1) BR9306207A (it)
CA (1) CA2092356A1 (it)
EE (1) EE9400068A (it)
ES (1) ES2105923B1 (it)
FR (1) FR2689398B1 (it)
GR (1) GR930100111A (it)
IL (1) IL105169A0 (it)
IT (1) IT1264332B1 (it)
LV (1) LV10191B (it)
MD (1) MD940152A (it)
MX (1) MX9301922A (it)
NO (1) NO931246L (it)
NZ (1) NZ247188A (it)
OA (1) OA10102A (it)
PH (1) PH31116A (it)
PT (1) PT101238A (it)
SI (1) SI9300144A (it)
WO (1) WO1993019762A1 (it)
YU (1) YU23993A (it)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5827727A (en) * 1990-02-01 1998-10-27 Emory University Method of resolution of 1,3-oxathiolane nucleoside enantiomers
US5444063A (en) * 1990-12-05 1995-08-22 Emory University Enantiomerically pure β-D-dioxolane nucleosides with selective anti-Hepatitis B virus activity
US6200952B1 (en) * 1993-06-02 2001-03-13 Sciclone Pharmaceuticals, Inc. Combination therapy method for treating chronic hepatitis B
US5587362A (en) * 1994-01-28 1996-12-24 Univ. Of Ga Research Foundation L-nucleosides
WO1996010649A1 (en) * 1994-09-30 1996-04-11 Southwest Foundation For Biomedical Research Isolated human hepatitis b virus polymerase and uses thereof
US6391859B1 (en) 1995-01-27 2002-05-21 Emory University [5-Carboxamido or 5-fluoro]-[2′,3′-unsaturated or 3′-modified]-pyrimidine nucleosides
US5703058A (en) 1995-01-27 1997-12-30 Emory University Compositions containing 5-fluoro-2',3'-didehydro-2',3'-dideoxycytidine or a mono-, di-, or triphosphate thereof and a second antiviral agent
US5808040A (en) * 1995-01-30 1998-09-15 Yale University L-nucleosides incorporated into polymeric structure for stabilization of oligonucleotides
US6296882B1 (en) * 2000-06-12 2001-10-02 Manuel Viamonte, Jr. Non-toxic mucosal disinfectant containing isopropyl alcohol, sesame oil, and lemon oil
US8076303B2 (en) 2005-12-13 2011-12-13 Spring Bank Pharmaceuticals, Inc. Nucleotide and oligonucleotide prodrugs
EP2427213B1 (en) * 2009-05-08 2015-04-01 Sciclone Pharmaceuticals, Inc. Alpha thymosin peptides as vaccine enhancers

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE147774C (it) *
US4211773A (en) * 1978-10-02 1980-07-08 Sloan Kettering Institute For Cancer Research 5-Substituted 1-(2'-Deoxy-2'-substituted-β-D-arabinofuranosyl)pyrimidine nucleosides
US4594339A (en) * 1982-04-06 1986-06-10 Sloan-Kettering Institute For Cancer Research Anti-herpes virus compositions containing 5-substituted 1-2'(deoxy-2-'-substituted-β-d-arabinofuranosyl)pyrimedene nucleosides
US4666892A (en) * 1984-03-06 1987-05-19 Sloan-Kettering Memorial Cancer Center Method and composition for hepatitis treatment with pyrimidine nucleoside compounds

Also Published As

Publication number Publication date
MD940152A (ro) 1995-12-31
LV10191A (lv) 1994-10-20
EP0565412A1 (en) 1993-10-13
MX9301922A (es) 1993-10-01
NO931246L (no) 1993-10-07
AU3530293A (en) 1993-10-07
FR2689398B1 (fr) 1994-11-18
OA10102A (en) 1996-12-18
CN1081879A (zh) 1994-02-16
EE9400068A (et) 1995-12-15
SI9300144A (en) 1994-03-31
WO1993019762A1 (en) 1993-10-14
FR2689398A1 (fr) 1993-10-08
BE1009181A5 (fr) 1996-12-03
YU23993A (sh) 1997-05-28
AP9300513A0 (en) 1993-04-30
AU662804B2 (en) 1995-09-14
PT101238A (pt) 1994-03-31
CA2092356A1 (en) 1993-10-07
AP372A (en) 1994-11-24
ES2105923A1 (es) 1997-10-16
ITTO930226A0 (it) 1993-04-05
NO931246D0 (no) 1993-03-31
LV10191B (en) 1995-04-20
GR930100111A (el) 1993-12-30
ITTO930226A1 (it) 1994-10-05
PH31116A (en) 1998-02-28
ES2105923B1 (es) 1998-07-01
IL105169A0 (en) 1993-07-08
US5432165A (en) 1995-07-11
JPH069403A (ja) 1994-01-18
NZ247188A (en) 1995-05-26
BR9306207A (pt) 1998-06-23

Similar Documents

Publication Publication Date Title
ITMI931522A1 (it) Composizione farmaceutiche per il trattamento dell'infezione da virus dell'epatite b (hbv)
ATE219366T1 (de) Verwendung von 5-fluoro-2'-deoxy-3'-thiacytidin zur behandlung von hepatitis b
LU90911I2 (fr) Antig-ne recombinant comprenant les s-quences pre-S1 et S du virus de l'h-patite B ingr-dient actif de hepacare
EP0676954A4 (en) HIV LOCK VIRUS.
IT1237999B (it) Trattamento di malattie associate ad infezioni di hiv
FI933902A7 (fi) Substituoidut sykloheksaanijohdannaiset sairauksien hoitamiseksi
IT1264332B1 (it) Composizione per il trattamento di infezioni e malattie causate dal virus dell'epatite b (hpv)
IT8009551A0 (it) E-5-(2-alogenovinil-)-2'deossicitidine, loro metodo di preparazione e loro impiego per il trattamentodi malattie da virus
EP0689455A4 (en) THERAPEUTIC STRATEGIES FOR INFECTIONS WITH IMMUNE INFECTING CLUSTER VIRUS
PT97749A (pt) Processo para a preparacao de composicoes farmaceuticas contendo dsarn apropriadas para o diagnostico e o tratamento de hepatite viral
NO940810D0 (no) Behandling av virusinfeksjoner
IT1271567B (it) Procedimento per l'ulteriore trattamento di salcicce
PT87004A (pt) Process for the preparation of compositions for the treatment of viral infections and composites 3'-azide-2',3'-didesoxy-in osine and 3'-fluoro-2',3'-didesoxyguanosine
IT1228296B (it) Polveri ceramiche per l'applicazione elettrostatica di polveri e processo per produrle.
PT88420A (pt) Process for the preparation of pharmaceutical compositions containing 1-(2'-deoxy-2'-fluoro-beta-d-arabinofuranosyl)-5-ethyluracil and a method for treating hepatitis virus infections by using said compositions
EP0833668A4 (en) INHIBITATION OF THE HEPATITIS B VIRUS REPLICATION
IT1289238B1 (it) Composizioni farmaceutiche per il trattamento di infezioni virali comprendenti una 4 arilcumarina
EP0452360A4 (en) Methods and compositions for the prophylaxis and treatment of hepatitis b virus infections
DE59304804D1 (de) Verfahren zur Herstellung von 3-(2'-Oxyethyl)-dihydro-2-(3H)furanonen
IT8221787A0 (it) Procedimento per la preparazione di antigene superficiale puro dell'epatite b da plasma umano.
IT1225262B (it) Metodo per la sensibilizzazione di piccoli animali all'infezione da virus dell'immunodeficienza umana (hiv)
EP0655919A4 (en) TREATING VIRUS INFECTIONS IN HUMANS.
ZA932271B (en) Compositions for the treatment of infection and disease caused by hepatitis B virus (HBV)
JPS6429A (en) Antiviral agent
FI924278A7 (fi) BCRF1:n antagonistit Epstein-Barr-virusinfektioiden hoitamiseksi

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970430